首页> 外文期刊>Current pharmaceutical design >Liquid-based Cytology With HPV Triage of Low-grade Cytological Abnormalities Versus Conventional Cytology in Cervical Cancer Screening.
【24h】

Liquid-based Cytology With HPV Triage of Low-grade Cytological Abnormalities Versus Conventional Cytology in Cervical Cancer Screening.

机译:宫颈癌筛查中低级细胞学异常与常规细胞学的HPV分流的液基细胞学。

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: Liquid-based cytology with supplementary human papillomavirus triage (LBC+HPV triage) of low-grade cytological abnormalities may improve the detection of cervical intraepithelial neoplasia (CIN) compared with conventional cytology. To investigate this subject, LBC+HPV triage and conventional cytology were alternated in a population-based screening setting. Cases with abnormal cytology were referred for colposcopy. Methods: We compared the performance of LBC+HPV triage [n=4059] and conventional cytology [n=4261] in detecting CIN2 or worse [CIN2+] and CIN3 or worse [CIN3+]. We used logistic regression to assess CIN detection rates and abnormal cytology rates, which yielded unadjusted odds ratios (OR) and corresponding 95% confidence intervals (CI). We computed adjusted ORs from a multivariate logistic regression model that included potential confounders such as age, screening centre and time period. Results: We found similar detection rates of CIN2+ by LBC+HPV triage and conventional cytology; the adjusted OR for the comparison of CIN detection rates was 0.87 (95% CI: 0.60-1.26) for CIN2+ and 1.00 (95% CI: 0.64-1.58) for CIN3+. We also found similar positive predictive values between methods. Thus, there was no advantage in using LBC+HPV triage as compared to conventional cytology in terms of sensitivity, specificity and positive and negative predictive value to detect histologically confirmed CIN2+ and CIN3+. Conclusions: LBC+HPV triage may lead to a reduction in unnecessary work-ups for women with abnormal cytological lesions who are negative for high-risk HPV. It is important to continuously monitor abnormal cytology rates, both when testing a new method, and after the new method has become routine.
机译:目的:液基细胞学检查与低度细胞学异常的补充人乳头瘤病毒分诊(LBC + HPV分诊)相比常规细胞学检查可以改善宫颈上皮内瘤变(CIN)的检测。为了调查该主题,在基于人群的筛查环境中交替进行LBC + HPV分类和常规细胞学检查。细胞学异常的病例需进行阴道镜检查。方法:我们比较了LBC + HPV分类[n = 4059]和常规细胞学检查[n = 4261]在检测CIN2或更差[CIN2 +]和CIN3或更差[CIN3 +]方面的性能。我们使用逻辑回归来评估CIN检测率和异常细胞学率,从而得出未调整的优势比(OR)和相应的95%置信区间(CI)。我们从包括年龄,筛查中心和时间段等潜在混杂因素的多元逻辑回归模型中计算出调整后的OR。结果:我们发现,通过LBC + HPV分诊和常规细胞学检测,CIN2 +的检出率相近;对于CIN2 +,用于比较CIN检测率的校正后OR为0.87(95%CI:0.60-1.26),对于CIN3 +为1.00(95%CI:0.64-1.58)。我们还发现两种方法之间的阳性预测值相似。因此,与传统的细胞学相比,使用LBC + HPV分诊在检测组织学确认的CIN2 +和CIN3 +的敏感性,特异性以及阳性和阴性预测值方面没有优势。结论:LBC + HPV分诊可减少异常细胞学病变,高危HPV阴性的女性不必要的检查。在测试新方法时以及在新方法成为常规方法之后,连续监测异常细胞学率非常重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号